These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 2304632

  • 1. MPTP, MPDP+ and MPP+ cause decreases in dopamine content in mouse brain slices.
    Wilson JA, Doyle TJ, Lau YS.
    Neurosci Lett; 1990 Jan 01; 108(1-2):213-8. PubMed ID: 2304632
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP): prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide.
    Cosi C, Marien M.
    Brain Res; 1998 Oct 26; 809(1):58-67. PubMed ID: 9795136
    [Abstract] [Full Text] [Related]

  • 4. The action of MPTP on synaptic transmission is affected by changes in Ca2+ concentrations.
    Wilson JA, Lau YS, Gleeson JG, Wilson JS.
    Brain Res; 1991 Feb 15; 541(2):342-6. PubMed ID: 1647250
    [Abstract] [Full Text] [Related]

  • 5. Effect of MPTP and its pyridinium metabolites on monoamine uptake and on central catecholamine neurons in mice.
    Jonsson G, Nwanze E, Luthman J, Sundström E.
    Acta Physiol Scand; 1986 Oct 15; 128(2):187-94. PubMed ID: 3535380
    [Abstract] [Full Text] [Related]

  • 6. MPDP+ causes a non-reversible decrease in neostriatal synaptic transmission in mouse brain slice.
    Wilson JA, Wilson JS, Weight FF.
    Brain Res; 1987 Nov 10; 425(2):376-9. PubMed ID: 2827846
    [Abstract] [Full Text] [Related]

  • 7. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its toxic metabolites on the physicochemical property of the liposomal membrane in relation to their cytochrome P-450 inhibition.
    Das NP, Shahi GS, Moochhala SM, Sato T, Sunamoto J.
    Chem Phys Lipids; 1992 Oct 10; 62(3):303-10. PubMed ID: 1468127
    [Abstract] [Full Text] [Related]

  • 8. Actions of MPTP and MPP+ on synaptic transmission in guinea-pig hippocampal slices.
    Galvan M, Kupsch A, ten Bruggencate G.
    Exp Neurol; 1987 May 10; 96(2):289-98. PubMed ID: 3032664
    [Abstract] [Full Text] [Related]

  • 9. 1-Methyl-4-phenylpyridinium (MPP+) but not 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) serves as methyl donor for dopamine: a possible mechanism of action.
    Charlton CG.
    J Geriatr Psychiatry Neurol; 1992 May 10; 5(2):114-8. PubMed ID: 1590912
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes.
    Chiba K, Trevor AJ, Castagnoli N.
    Biochem Biophys Res Commun; 1985 May 16; 128(3):1228-32. PubMed ID: 3873939
    [Abstract] [Full Text] [Related]

  • 12. 1-Methyl-4-phenyl-2,3-dihydropyridinium is transformed by ubiquinone to the selective nigrostriatal toxin 1-methyl-4-phenylpyridinium.
    Shi H, Noguchi N, Xu Y, Niki E.
    FEBS Lett; 1999 Nov 19; 461(3):196-200. PubMed ID: 10567696
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of the tyrosine hydroxylase system by MPTP, 1-methyl-4-phenylpyridinium ion (MPP+) and the structurally related compounds in vitro and in vivo.
    Nagatsu T, Hirata Y.
    Eur Neurol; 1987 Nov 19; 26 Suppl 1():11-5. PubMed ID: 2884110
    [Abstract] [Full Text] [Related]

  • 14. Nullification of a positive correlation between urinary contents of alpha1-microglobulin and ulinastatin with intracerebroventricularly administered 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridinium (MPP+) in mice.
    Kaku K, Shikimi T, Kamisaki Y, Inagaki T, Ishino H, Okunishi H, Takaori S.
    Psychopharmacology (Berl); 1998 Apr 19; 136(4):374-8. PubMed ID: 9600583
    [Abstract] [Full Text] [Related]

  • 15. Trace dosages of the neurotoxins MPTP and MPP+ may affect brain dopamine in vivo.
    Bagchi SP.
    Life Sci; 1992 Apr 19; 51(5):389-96. PubMed ID: 1625529
    [Abstract] [Full Text] [Related]

  • 16. Comparative toxicity of MPTP, MPP+ and 3,3-dimethyl-MPDP+ to dopaminergic neurons of the rat substantia nigra.
    Sayre LM, Arora PK, Iacofano LA, Harik SI.
    Eur J Pharmacol; 1986 May 13; 124(1-2):171-4. PubMed ID: 3487462
    [Abstract] [Full Text] [Related]

  • 17. Reversible inhibition and mechanism-based irreversible inactivation of monoamine oxidases by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Singer TP, Salach JI, Crabtree D.
    Biochem Biophys Res Commun; 1985 Mar 15; 127(2):707-12. PubMed ID: 3872126
    [Abstract] [Full Text] [Related]

  • 18. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ, Heavens RP, McBride CS.
    Brain Res; 1988 Mar 08; 443(1-2):101-16. PubMed ID: 3258784
    [Abstract] [Full Text] [Related]

  • 19. Impaired mutagenic activities of MPDP(+) (1-methyl-4-phenyl-2,3-dihydropyridinium) and MPP(+) (1-methyl-4-phenylpyridinium) due to their interactions with methylxanthines.
    Ulanowska K, Piosik J, Gwizdek-Wiśniewska A, Wegrzyn G.
    Bioorg Med Chem; 2007 Aug 01; 15(15):5150-7. PubMed ID: 17533133
    [Abstract] [Full Text] [Related]

  • 20. Changes in lipid peroxidation induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium in mouse brain homogenates.
    Ríos C, Tapia R.
    Neurosci Lett; 1987 Jun 26; 77(3):321-6. PubMed ID: 3497366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.